These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 18703023

  • 1. Comparison of CYP1A2 and NAT2 phenotypes between black and white smokers.
    Muscat JE, Pittman B, Kleinman W, Lazarus P, Stellman SD, Richie JP.
    Biochem Pharmacol; 2008 Oct 01; 76(7):929-37. PubMed ID: 18703023
    [Abstract] [Full Text] [Related]

  • 2. Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites.
    Butler MA, Lang NP, Young JF, Caporaso NE, Vineis P, Hayes RB, Teitel CH, Massengill JP, Lawsen MF, Kadlubar FF.
    Pharmacogenetics; 1992 Jun 01; 2(3):116-27. PubMed ID: 1306111
    [Abstract] [Full Text] [Related]

  • 3. Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities.
    Fuchs P, Haefeli WE, Ledermann HR, Wenk M.
    Eur J Clin Pharmacol; 1999 Jan 01; 54(11):869-76. PubMed ID: 10027663
    [Abstract] [Full Text] [Related]

  • 4. [Determination of caffeine metabolite for the evaluation of N-acetyltransferase, CYP1A2 and xanthine oxidase activities].
    Lu JF, Yi T, Cao XM, Zhuo HT, Ling SS.
    Yao Xue Xue Bao; 1997 Nov 01; 32(11):813-8. PubMed ID: 11596199
    [Abstract] [Full Text] [Related]

  • 5. Caffeine metabolic ratios for the in vivo evaluation of CYP1A2, N-acetyltransferase 2, xanthine oxidase and CYP2A6 enzymatic activities.
    Hakooz NM.
    Curr Drug Metab; 2009 May 01; 10(4):329-38. PubMed ID: 19519341
    [Abstract] [Full Text] [Related]

  • 6. Analysis of urinary caffeine metabolites to assess biotransformation enzyme activities by reversed-phase high-performance liquid chromatography.
    Krul C, Hageman G.
    J Chromatogr B Biomed Sci Appl; 1998 May 08; 709(1):27-34. PubMed ID: 9653923
    [Abstract] [Full Text] [Related]

  • 7. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
    Landi MT, Zocchetti C, Bernucci I, Kadlubar FF, Tannenbaum S, Skipper P, Bartsch H, Malaveille C, Shields P, Caporaso NE, Vineis P.
    Cancer Epidemiol Biomarkers Prev; 1996 Sep 08; 5(9):693-8. PubMed ID: 8877060
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effect of pregnancy on cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activities in humans.
    Tsutsumi K, Kotegawa T, Matsuki S, Tanaka Y, Ishii Y, Kodama Y, Kuranari M, Miyakawa I, Nakano S.
    Clin Pharmacol Ther; 2001 Aug 08; 70(2):121-5. PubMed ID: 11503005
    [Abstract] [Full Text] [Related]

  • 11. NAT2 and CYP1A2 phenotyping with caffeine: head-to-head comparison of AFMU vs. AAMU in the urine metabolite ratios.
    Nyéki A, Buclin T, Biollaz J, Decosterd LA.
    Br J Clin Pharmacol; 2003 Jan 08; 55(1):62-7. PubMed ID: 12534641
    [Abstract] [Full Text] [Related]

  • 12. Urinary mutagenicity, CYP1A2 and NAT2 activity in textile industry workers.
    Fanlo A, Sinuès B, Mayayo E, Bernal L, Soriano A, Martínez-Jarreta B, Martínez-Ballarín E.
    J Occup Health; 2004 Nov 08; 46(6):440-7. PubMed ID: 15613766
    [Abstract] [Full Text] [Related]

  • 13. Exposure levels and cytochrome P450 1A2 activity, but not N-acetyltransferase, glutathione S-transferase (GST) M1 and T1, influence urinary mutagen excretion in smokers.
    Pavanello S, Simioli P, Lupi S, Gregorio P, Clonfero E.
    Cancer Epidemiol Biomarkers Prev; 2002 Oct 08; 11(10 Pt 1):998-1003. PubMed ID: 12376499
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk.
    Le Marchand L, Hankin JH, Wilkens LR, Pierce LM, Franke A, Kolonel LN, Seifried A, Custer LJ, Chang W, Lum-Jones A, Donlon T.
    Cancer Epidemiol Biomarkers Prev; 2001 Dec 08; 10(12):1259-66. PubMed ID: 11751443
    [Abstract] [Full Text] [Related]

  • 16. Analysis of within-subject variation of caffeine metabolism when used to determine cytochrome P4501A2 and N-acetyltransferase-2 activities.
    McQuilkin SH, Nierenberg DW, Bresnick E.
    Cancer Epidemiol Biomarkers Prev; 1995 Mar 08; 4(2):139-46. PubMed ID: 7742721
    [Abstract] [Full Text] [Related]

  • 17. Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities.
    Relling MV, Lin JS, Ayers GD, Evans WE.
    Clin Pharmacol Ther; 1992 Dec 08; 52(6):643-58. PubMed ID: 1458773
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Carotenoids/vitamin C and smoking-related bladder cancer.
    Castelao JE, Yuan JM, Gago-Dominguez M, Skipper PL, Tannenbaum SR, Chan KK, Watson MA, Bell DA, Coetzee GA, Ross RK, Yu MC.
    Int J Cancer; 2004 Jun 20; 110(3):417-23. PubMed ID: 15095308
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.